Evidence map›Paper›PMID 33966186›Full record

ReviewReproductive sciences (Thousand Oaks, Calif.)2021

The Role of Bone Morphogenetic Protein 4 in Ovarian Function and Diseases.

Dongyong Yang, Xiao Yang, Fangfang Dai, Yanqing Wang, Yi Yang, Min Hu, Yanxiang Cheng

Abstract readReview
PubMed Publisher
In one paragraph

Review in Reproductive sciences (Thousand Oaks, Calif.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. ELK1 regulates BMPR1B transcriptional activity in ovine granulosa cells.Frontiers in cell and developmental biology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Dongyong YangDepartment of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Xiao YangDepartment of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, 100044, China.
Fangfang DaiDepartment of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Yanqing WangDepartment of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Yi YangSchool of Physics & Technology, Key Laboratory of Artificial Micro/Nano Structure of Ministry of Education, Wuhan University, Wuhan, 430072, China. yangyiys@whu.edu.cn.
Min HuDepartment of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. huminmmmmm@whu.edu.cn.
Yanxiang ChengDepartment of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. yanxiangCheng@whu.edu.cn.ORCID http://orcid.org/0000-0002-9218-5246
Wuhan University · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone morphogenetic proteins (BMPs) are the largest subfamily of the transforming growth factor-β (TGF-β) superfamily. BMP4 is a secreted protein that was originally identified due to its role in bone and cartilage development. Over the past decades, extensive literature has indicated that BMP4 and its receptors are widely expressed in the ovary. Dysregulation of BMP4 expression may play a vital role in follicular development, polycystic ovary syndrome (PCOS), and ovarian cancer. In this review, we summarized the expression pattern of BMP4 in the ovary, focused on the role of BMP4 in follicular development and steroidogenesis, and discussed the role of BMP4 in ovarian diseases such as polycystic ovary syndrome and ovarian cancer. Some studies have shown that the expression of BMP4 in the ovary is spatiotemporal and species specific, but the effects of BMP4 seem to be similar in follicular development of different species. In addition, BMP4 is involved in the development of hyperandrogenemia in PCOS and drug resistance in ovarian cancer, but further research is still needed to clarify the specific mechanisms.

Indexed as

AnimalsBone Morphogenetic Protein 4FemaleHumansOvarian FollicleOvarian NeoplasmsOvaryPolycystic Ovary SyndromeBMP4 protein, humanBone Morphogenetic Protein 4Bone morphogenetic protein 4Follicular developmentOvarian cancerPolycystic ovary syndromeSteroidogenesis

Identifiers

PMID33966186
OpenAlexW3160904684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.